FEATUREDLatestScienceTOP STORIES

UCLA’s Breakthrough in Battling Baldness


For centuries, certain dreams have proven consistently evasive for us as a species. Most persistent among these have been untold riches, eternal youth, and……perhaps the most intimate of all – the search for a cure for baldness. From the bizarre concoctions of Ancient Egypt’s hair loss remedies, blending dates with donkey hooves, to the Native American reliance on yucca juice, the battle against thinning locks has been as creative as it has been desperate. Today, however, a new approach from UCLA scientists is being tested in clinical trials. Enter PP405, a topical molecule designed to reawaken dormant follicles and potentially change the landscape of hair regrowth. It is an experimental drug, not an approved treatment, and the evidence so far is early.

Update (10 November 2026): In October 2026 Pelage Pharmaceuticals announced that the first patient had been dosed in its Phase 2/3 AWAKEN trial of PP405, a 12-month, randomised, placebo-controlled study expected to enrol about 600 men with androgenetic alopecia in the US and Canada. PP405 is still not approved anywhere.

Hair loss is no trivial matter. Triggered by a cocktail of culprits—ageing, stress, hormonal shifts, and, of course, those pesky genetics—it is very common in both men and women. For many, it’s more than just a cosmetic concern; it’s a psychological burden, a dent in confidence that no amount of hats can fully conceal. Traditional remedies like Rogaine and Propecia—detailed in this Mayo Clinic guide to hair loss treatments—help some people, but results vary and they mainly slow loss or thicken existing hair, leaving many looking for something more. Could PP405, which came out of UCLA research, offer a new option?

The Science Behind the Strands

At its core, PP405 is a small but mighty molecule, designed to shake dormant follicle stem cells out of their slumber. These cells, nestled in the scalp, often lie inactive due to a protein that keeps them in a state of perpetual rest. The UCLA team—William Lowry, Heather Christofk and Michael Jung—worked on how hair follicle stem cells use energy, and PP405 is designed to shift that metabolism and wake the cells up. The aim is to produce new hair growth from follicles that have gone quiet, rather than only supporting follicles that are already active. Curious about the science? Dive into how follicle stem cells work.

The journey has been a long one, from laboratory work on follicle stem cell metabolism to human trials. In 2025 Pelage reported topline results from a Phase 2a trial of 78 men and women with androgenetic alopecia, who applied PP405 or a placebo once daily for four weeks. The study met its primary safety endpoint, with no systemic absorption detected. In an exploratory analysis, 31% of men with a higher degree of hair loss who received PP405 showed a greater than 20% increase in hair density at week eight, compared with 0% on placebo. These are company-reported results from a small trial and a subgroup, so they are a promising signal rather than proof. The lead target is pattern baldness.

A Crowning Achievement in the Making

The researchers co-founded Pelage Pharmaceuticals, a company set up to develop the compound commercially. Larger trials and the regulatory process, including FDA approval, still lie ahead. Learn more about Pelage Pharmaceuticals and its research.

Of course, caution is needed. No hair-loss product works for everyone, and early-stage results often do not hold up in larger trials. If it does succeed, the company has said it is also interested in chemotherapy-induced hair loss, though that is a separate question from pattern baldness and autoimmune alopecia, which PP405 has not been shown to treat.

Looking Ahead: A Follicle-Filled Future?

As Pelage Pharmaceuticals presses forward, the world watches with bated breath. Will PP405 prove to be a real advance in treating pattern hair loss, or will it join the long list of promising compounds that fell short in larger trials? Only bigger, longer studies can say. Explore the future of hair regrowth technology to see what else is in development.

So, whether you’re a follicly challenged soul or simply curious about the next big thing in hair regrowth science, keep an eye on PP405, but treat it as early research rather than a treatment you can get.

We’d love your comments on today’s topic!

For more stories like this one, click here.

Thought for the day:

“Only in the darkness can you see the stars.” — Martin Luther King, Jr.

Leave a Reply

Your email address will not be published. Required fields are marked *